Nitrogil 2.6 CR is a sustained-release formulation of Nitroglycerin 2.6 mg, indicated for the prevention and management of angina pectoris (chest pain). It belongs to the class of organic nitrates and is widely used in cardiovascular care to reduce the frequency and severity of anginal attacks. Nitroglycerin works by relaxing and widening blood vessels, improving blood flow and reducing the workload of the heart. By lowering myocardial oxygen demand, Nitrogil 2.6 CR helps prevent chest pain episodes and supports better cardiac performance during daily activities.
Nitroglycerin 2.6 mg acts as a vasodilator by relaxing smooth muscles of blood vessels, improving coronary blood flow and reducing oxygen demand on the heart to prevent angina attacks.
Prevents Angina Attacks
Helps reduce the frequency and severity of chest pain episodes.
Reduces Cardiac Workload
Decreases the oxygen demand of the heart by improving blood vessel relaxation.
Improves Blood Flow
Enhances coronary circulation for better oxygen supply to the heart muscles.
Sustained-Release Action
Provides prolonged therapeutic effect for long-term angina management.
Well-Tolerated Therapy
Suitable for regular use under medical supervision.
Take the tablet exactly as prescribed by a healthcare professional. Do not crush or chew the tablet. Regular monitoring of blood pressure is advised during therapy.
May include headache, dizziness, flushing, low blood pressure, or light-headedness. Consult a healthcare provider if side effects persist or worsen.
Globus Labs brings you WHO-GMP–certified, high-quality Nitroglycerin 2.6 mg Tablets IP sourced from reputed pharmaceutical manufacturers. Nitrogil 2.6 CR is formulated to deliver safe, potent, and clinically trusted support.
Whether you’re seeking a franchise opportunity, exploring wholesale distribution, or evaluating Globus Labs for international trade, we’re here to help you build a strong, profitable partnership. Let’s discuss how we can grow together and create meaningful value for your business.